Browse Category

Stock News News 9 December 2025 - 14 December 2025

Lumentum (LITE) Stock: Latest News, Forecasts, and Analyst Targets as AI Optics Volatility Spikes (Dec. 14, 2025)

Lumentum (LITE) Stock: Latest News, Forecasts, and Analyst Targets as AI Optics Volatility Spikes (Dec. 14, 2025)

Lumentum Holdings (NASDAQ: LITE) stock saw sharp volatility into Dec. 14, 2025. Here’s what’s driving the move, what analysts forecast next, and key AI optics catalysts to watch. Updated: Sunday, December 14, 2025 — U.S. markets are closed today, but Lumentum Holdings Inc. (NASDAQ: LITE) is in focus after a dramatic late-week swing that underscored both the stock’s AI-infrastructure upside narrative and its valuation-driven volatility. On the most recent trading day (Friday, Dec. 12), Lumentum last traded around $324.35, down 12.83% (about -$47.74) versus the prior close, after trading as low as $319.29 and as high as $365.88. Reuters data
Antofagasta plc Stock (LSE: ANTO) News, Forecasts and Analyst Targets — What Investors Are Watching on December 13, 2025

Antofagasta plc Stock (LSE: ANTO) News, Forecasts and Analyst Targets — What Investors Are Watching on December 13, 2025

Antofagasta plc shares are hovering near 52-week highs as copper prices surge. Here’s the latest ANTO share price action, company updates, dividends, production guidance, and what analyst forecasts imply for 2026. Published: December 13, 2025 Antofagasta plc (LSE: ANTO) is having the kind of year copper bulls daydream about: a strong share-price run, a commodity tailwind that just refuses to quit, and a steady drumbeat of project updates aimed at boosting production over the medium term. But as of December 13, 2025, the stock also sits in that classic “great story, expensive expectations” zone—where the copper narrative is hot, yet
Sheng Siong Group Ltd (SGX:OV8) Stock: Latest News, Analyst Targets, Dividend Outlook and 2026 Catalysts (Dec 13, 2025)

Sheng Siong Group Ltd (SGX:OV8) Stock: Latest News, Analyst Targets, Dividend Outlook and 2026 Catalysts (Dec 13, 2025)

Singapore’s defensive supermarket giant has spent 2025 doing something supermarkets are not supposed to do: excite the market. Sheng Siong Group Ltd (SGX:OV8) is trading near its 52‑week high, analysts are debating whether the “voucher tailwind” is already priced in, and the stock has landed on the Straits Times Index (STI) reserve list—often a prelude (not a promise) to wider index attention. Investing.com+2The Business Times+2 Below is a detailed roundup of the most recent news, forecasts, and analyst commentary available as of 13 December 2025, plus the company fundamentals that matter for anyone tracking the next move in Sheng Siong
Reddit Stock (RDDT) News Today, Dec. 12, 2025: Australia Lawsuit, Verified Profiles Test, and Fresh 2026 Analyst Price Targets

Reddit Stock (RDDT) News Today, Dec. 12, 2025: Australia Lawsuit, Verified Profiles Test, and Fresh 2026 Analyst Price Targets

Dec. 12, 2025 — Reddit, Inc. (NYSE: RDDT) is in the spotlight today as investors balance legal and regulatory headlines, new trust-and-safety product testing, and fresh Wall Street forecasts heading into 2026. RDDT shares were recently trading around $229.81, down about 1.6% on the day, with a market capitalization near $43.0 billion. While the stock’s day-to-day move is modest, the news cycle around Reddit has become meaningfully more active this week—especially with Australia’s new under-16 social media restrictions now live and major firms debating how AI will reshape internet traffic, ad economics, and platform “moats.” Reddit stock price today: where
Synopsys (SNPS) Stock News Today (Dec. 12, 2025): Analyst Upgrades, 2026 Forecast, and Key Risks After Q4 Earnings

Synopsys (SNPS) Stock News Today (Dec. 12, 2025): Analyst Upgrades, 2026 Forecast, and Key Risks After Q4 Earnings

Synopsys, Inc. (NASDAQ: SNPS) is back in the spotlight on Friday, December 12, 2025, as investors digest a fresh wave of analyst updates, management’s newly issued fiscal 2026 outlook, and headlines tied to earlier 2025 volatility. SNPS stock was trading around $477 in the latest available data, reflecting a market that’s weighing strong demand for advanced chip-design tools against integration and geopolitical risks. Below is a detailed roundup of the most current Synopsys stock news, forecasts, and analyses as of 12/12/2025, including what’s moving the stock, what Wall Street is modeling next, and the catalysts (and risks) that could shape
Vertiv (VRT) Stock News Today (Dec. 12, 2025): Malaysia Factory Expansion, Analyst Forecasts, and What Could Move Shares Next

Vertiv (VRT) Stock News Today (Dec. 12, 2025): Malaysia Factory Expansion, Analyst Forecasts, and What Could Move Shares Next

Vertiv Holdings Co. (NYSE: VRT) trades near $179 as it unveils plans for a new manufacturing facility in Malaysia aimed at AI-ready data center demand—here are the latest headlines, Wall Street forecasts, and the catalysts investors are watching into 2026. Dec. 12, 2025 — Vertiv Holdings Co. (NYSE: VRT), a major supplier of power and thermal infrastructure used in data centers, is back in focus on Friday after announcing an Asia manufacturing expansion while analysts continue to debate valuation after a powerful run tied to AI-driven data center spending. Shares of Vertiv were trading around $178.66 in the latest update
AEM Holdings Ltd Stock (SGX:AWX) News, Share Buybacks, Analyst Targets and Outlook — 12 December 2025

AEM Holdings Ltd Stock (SGX:AWX) News, Share Buybacks, Analyst Targets and Outlook — 12 December 2025

(SEO): AEM Holdings Ltd (SGX:AWX) is back in focus after early-December share buybacks, a 9M2025 profit swing, and fresh analyst debate over AI/HPC upside versus valuation and legal overhangs. AEM Holdings Ltd (SGX:AWX / AWX.SI) — not to be confused with the US-listed gold miner that also uses “AEM” as a ticker — is a Singapore-listed semiconductor test and handling solutions company riding an industry storyline that refuses to die: AI compute keeps getting hotter, denser, and harder to test, and the “test” part of the semiconductor value chain suddenly matters a lot again. As of 12 December 2025, AEM’s
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 12.12.2025

{“@context”:”https://schema.org”,”@type “:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-12-12-2025/#live”,”headline”:”Stock Market Today 12.12.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-12-12T00:00:02-05:00″,”dateModified”:”2025-12-13T00:00:03-05:00″,”coverageStartTime”:”2025-12-12T00:00:02-05:00″,”coverageEndTime”:”2025-12-13T00:00:03-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-12-12-2025/#live/u/5f8d6b328a97e803″,”headline”:”Fortescue Ltd (ASX: FMG) Stock After the Dec. 12, 2025 Close: Key News, Forecasts, and Watchlist Ahead of Open”,”articleBody”:”Fortescue Ltd (FMG) closed Friday at around A$22.98, up 1.06%, keeping it near the 52-week high with a daily range of A$22.64-A$23.20. The stock is benefiting from a risk-on backdrop as the Su0026P/ASX 200 and Materials sector rally, supported by stronger global commodity prints and a positive iron ore backdrop. Iron ore prices hovered around US$106/tonne, a level investors regard as tradable for Pilbara
Arrowhead Pharmaceuticals (ARWR) Stock Near 52‑Week High After FDA Approval and New Alzheimer’s Trial: Latest News & Forecasts as of December 11, 2025

Arrowhead Pharmaceuticals (ARWR) Stock Near 52‑Week High After FDA Approval and New Alzheimer’s Trial: Latest News & Forecasts as of December 11, 2025

Arrowhead Pharmaceuticals (NASDAQ: ARWR) has quietly turned into one of 2025’s wildest biotech comeback stories. After years as a perpetually “promising” RNA interference (RNAi) platform, the company now has: The stock price has responded in full drama mode. As of the afternoon of December 11, 2025, Arrowhead shares are trading around $70, having touched intraday highs above $72 and notching a new 52‑week high in the low‑$70s. Investing.com+1 Over the last month, the stock has climbed from the low‑$40s to roughly $70 — a gain on the order of three‑quarters in just a few weeks. Investing.com At today’s levels, Arrowhead’s
MercadoLibre (MELI) Stock Today: Latest News, Q3 2025 Results, Analyst Forecasts and Outlook as of December 9, 2025

MercadoLibre (MELI) Stock Today: Latest News, Q3 2025 Results, Analyst Forecasts and Outlook as of December 9, 2025

MercadoLibre, Inc. (NASDAQ: MELI), Latin America’s leading e‑commerce and fintech platform, is ending 2025 in a curious position: business momentum remains extremely strong, but the stock has cooled after hitting record highs in June. As of December 9, 2025, MercadoLibre’s share price trades around $2,060–2,080 per share, implying a market capitalization of roughly $105 billion and a trailing P/E ratio just over 50x.StockAnalysis+1 The stock is up around 20%+ year to date, but sits roughly 18–20% below its 2025 peak near $2,645.FinancialContent+1 At the same time, MercadoLibre has: Here’s a deep dive into all the key news, forecasts and analyses
Booking Holdings (BKNG) Stock Today: Nasdaq Conference, Allegiant Deal, Options Whales and Fresh Forecasts (Dec. 9, 2025)

Booking Holdings (BKNG) Stock Today: Nasdaq Conference, Allegiant Deal, Options Whales and Fresh Forecasts (Dec. 9, 2025)

Booking Holdings Inc. Common Stock (NASDAQ: BKNG) is back in the spotlight on December 9, 2025, as investors digest a packed slate of catalysts: a high‑profile presentation at Nasdaq’s 53rd Investor Conference in London, a new airline partnership via Rocket Travel by Agoda, unusual options activity, and a wave of fresh institutional and analyst updates. As of the afternoon session on December 9, 2025, BKNG trades around $5,105 per share, down roughly 1.4% on the day, after opening at $5,153.99 and trading between $5,010 and $5,170 on intraday volume just under 100,000 shares. The stock sits below its recent high
Structure Therapeutics (GPCR) Stock Explodes on Obesity Pill Breakthrough: Latest News, Analyst Targets and 2026–2035 Outlook

Structure Therapeutics (GPCR) Stock Explodes on Obesity Pill Breakthrough: Latest News, Analyst Targets and 2026–2035 Outlook

Structure Therapeutics Inc. (NASDAQ: GPCR) has suddenly become one of the most talked‑about obesity‑drug names on Wall Street. As of mid‑day on December 9, 2025, Structure Therapeutics stock was trading around $69.98, up roughly 100% in a single session after the company unveiled strong mid‑stage data for its once‑daily oral GLP‑1 obesity pill, aleniglipron. GlobeNewswire+2Investors+2 Over the past six months, GPCR has already delivered a multi‑bagger move, with one analyst note calculating a ~241% gain even before today’s opening bell. The stock now sits near its 52‑week high, with a 52‑week range of about $13.22 to $94.90 and a market
1 3 4 5 6 7

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop